# VITEKTA
> **NDA203093** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2014-09-24
## Drug
- **FDA Application Number:** NDA203093
- **Application type:** New Drug Application
- **Brand name:** VITEKTA
- **Generic name:** Elvitegravir
- **Active ingredients:** ELVITEGRAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GILEAD SCIENCES INC
- **First approval:** 2014-09-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203093)
---
*MORVS · CC0 1.0*